Predictive value of bilirubin and serum γ-glutamyltranspeptidase levels in type-2 diabetes mellitus patients with acute coronary syndrome

Table 2 Comparison of laboratory indexes among group

	T2DM + ACS (n = 96)	T2DM (n = 85)	ACS (n = 90)	F value	P value
TBIL (μmol/L)	6.76 ± 0.70	10.72 ± 1.211	9.53 ± 1.031,2	384.2	< 0.0001
γ-GGT (U/L)	36.81 ± 2.98	32.22 ± 3.221	30.09 ± 3.291	110.2	< 0.0001
TC (mmol/L)	5.33 ± 0.43	4.24 ± 0.361	4.33 ± 0.401	213.1	< 0.0001
TG (mmol/L)	0.96 ± 0.33	1.02 ± 0.22	1.05 ± 0.201	2.923	0.0555
LDL-C (mmol/L)	2.41 ± 0.26	1.87 ± 0.241	2.28 ± 0.251,2	112.0	< 0.0001
HDL-C (mmol/L)	1.16 ± 0.07	1.19 ± 0.121	1.21 ± 0.111	5.750	0.0036
HbA1c (%)	8.19 ± 0.64	7.61 ± 0.601	5.33 ± 0.691,2	501.8	< 0.0001
LEVF (%)	44.92 ± 3.80	57.27 ± 6.391	52.19 ± 4.641	139.8	< 0.0001

¹P < 0.05 vs. T2DM + ACS.

²P < 0.05 vs. T2DM.

TBIL: Total bilirubin; γ-GGT: γ-glutamyltranspeptidase; TC: Total cholesterol; TG: Triglyceride; LDL-C: Low-density lipoprotein cholesterol; HDL-C: High-density lipoprotein cholesterol; HbA1c: Glycosylated hemoglobin; LEVF: Left ventricular ejection fraction; T2DM: Type-2 diabetes mellitus; ACS: Acute coronary syndrome.